Cocrystal Pharma, Inc.
USD1.05
-0.06 (-5.41%)
CEO
Sam Lee
IPO Date
2012-02-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.06
Prev. Close
$1.11
Day Low
$1.05
Day High
$1.09
52W Low
$0.86
52W High
$2.67
Market Cap
$0.01B
Volume
0.18M
| 50,000 |
| $0.95 |
| 13 Jan 2026 | Kornberg Roger D. | director | A-Award | Acquired | 24,615 | $1.10 |
| 13 Jan 2026 | PFENNIGER RICHARD C JR | director | A-Award | Acquired | 16,410 | $1.10 |
| 13 Jan 2026 | Lee Sam | President and Co-CEO | A-Award | Acquired | 49,229 | $1.10 |
| 13 Jan 2026 | Hassan Fred | director | A-Award | Acquired | 16,410 | $1.10 |
| 13 Jan 2026 | Martin James Joseph | Co-CEO and CFO | A-Award | Acquired | 49,229 | $1.10 |
| 13 Jan 2026 | FROST PHILLIP MD ET AL | director, 10 percent owner: | A-Award | Acquired | 24,615 | $1.10 |
| 13 Jan 2026 | Japour Anthony J | director | A-Award | Acquired | 16,410 | $1.10 |
| 13 Jan 2026 | Rubin Steven D | director | A-Award | Acquired | 16,410 | $1.10 |